Physician profile
Michael L Moretti
NPI 1033202056
$559.68
in general payments reported to CMS, 2019-2025
10 companies · $39.62 in 2025
The $39.62 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $18.54 · 2022: $56.21 · 2023: $180 · 2024: $141 · 2025: $39.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.42 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $154.50 | 2023 | |
| Astellas Pharma US INC | $137.47 | 2022-2024 | Cresemba |
| Amag Pharmaceuticals, INC. | $124.56 | 2019 | |
| Pfizer INC. | $28.59 | 2025 | |
| Sumitomo Pharma America, INC. | $25.55 | 2023 | Myfembree |
| Coopersurgical, INC. | $21.40 | 2022 | |
| Evofem Biosciences, INC. | $21.31 | 2022 | |
| Abbvie INC. | $18.54 | 2020 | |
| Ge Healthcare | $16.73 | 2024 | |
| Mayne Pharma Commercial LLC | $11.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moretti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.